from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2779c/-

LFCtreatmentdescriptionclass of inhibitor

0.336

Amikacinug/mL Amikacintranslation

0.509

Cap5-10ug/mL Capreomycintranslation

1.912

Rox10-50 ug/mL Roxithromycintranslation

-0.098

SM2-5 ug/mL Streptomycintranslation

0.555

Tet5-10 ug/mL Tetracyclinetranslation

-0.593

Rif0.2-5ug/mL Rifampicintranscription

0.109

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.593

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

3.083

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.430

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.001

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.021

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.167

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

3.934

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.626

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.155

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.191

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.548

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.315

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.509

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.754

KCN5-20 ug/mL Potassium cyaniderespiration

-0.329

NaN30.2-2 mM Sodium aziderespiration

1.375

Nigericin50 uM Nigericinrespiration

0.730

TRC10-150 ug/mL Triclosanrespiration

0.067

TRZ10-25 ug/mL Thioridazinerespiration

-0.382

Valinomycin0.5-10 uM Valinomycinrespiration

0.898

ZnSO42 mM ZnSO4respiration

-0.116

menadione6-10 ug/mL Menadionerespiration

-0.380

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.072

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.010

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.011

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.646

NRP_1Non-replicating persistence stage 1dosRassociated

0.170

Amp0.2mg/mL AmpicillincellWall

-0.446

Cephalexin20-100 ug/mL CephalexincellWall

0.068

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.343

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.045

EMB10-20 ug/mL EthambutolcellWall

-0.075

Eta12-40 ug/mL EthionamidecellWall

0.296

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.326

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.923

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.206

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.258

BZA0.12 mg/mL BenzamidearomaticAmides

-0.112

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.569

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.107

H2O24 mM hydrogen peroxideDNAdamaging

-0.393

Levo10 ug/mL LevofloxacinDNAdamaging

-0.564

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.076

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.392

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.541

UVUV-irradiationDNAdamaging

0.617

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.465

Antimycin12.5-50 ug/mL Antimycin A?

0.219

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.372

PA_110-50 ug/mL Antitubercular compound PA-1?

0.177

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.177

PA8240.2-2 ug/mL PA-824?

-0.375

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.322

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

-0.223

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.187

methoxatin10-20 ug/mL Methoxatin?